Ju‐Ming Wang
Impact in
- Immunology top 10%
- Immune Cell Function and Interaction
- Oncology top 5%
- Cytokine Signaling Pathways and Interactions
- Cancer-related Molecular Pathways
Papers in
-
- Ubiquitin and proteasome pathways 2
- FOXO transcription factor regulation 2
- Cell death mechanisms and regulation 2
- Immunology 14
- Biomarkers in Disease Mechanisms 7
- Immune cells in cancer 3
- Co-authors
- Hsin‐Fang Yang‐Yen (2 shared papers)Jyh-Rong Chao (1 shared paper)Wannhsin Chen (1 shared paper)Min‐Liang Kuo (1 shared paper)J. J. Yen (1 shared paper)Richard Jove (1 shared paper)Thomas P. Loughran (1 shared paper)Robyn Catlett-Falcone (1 shared paper)
- Journals
- Clinical and Translational Medicine (3 papers)Molecular and Cellular Biology (2 papers)Cancer Letters (1 paper)Journal of Biomedical Science (1 paper)Clinical Cancer Research (1 paper)
- Partner nations
- TaiwanUnited StatesJapan
In The Last Decade
Ju‐Ming Wang
27 papers receiving 1.4k citations
Ju‐Ming Wang's Hit Papers
Peers
Comparison fields: 5 of 85
- Immunology 380
- Oncology 460
- Genetics 133
- Cancer Research 177
- Pathology and Forensic Medicine 196
Countries citing papers authored by Ju‐Ming Wang
This map shows the geographic impact of Ju‐Ming Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ju‐Ming Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ju‐Ming Wang more than expected).
Fields of papers citing papers by Ju‐Ming Wang
This network shows the impact of papers produced by Ju‐Ming Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ju‐Ming Wang. The network helps show where Ju‐Ming Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Ju‐Ming Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 28 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Inhibition of STAT3 signaling leads to apoptosis of leukemic large granular lymphocytes and decreased Mcl-1 expression Hit paper breakdown → | 2001 | 504 |
| 2 | 1999 | 313 | |
| 3 | 2010 | 70 | |
| 4 | 2010 | 60 | |
| 5 | 2011 | 57 | |
| 6 | 2012 | 50 | |
| 7 | 2010 | 41 | |
| 8 | 2011 | 40 | |
| 9 | 2022 | 27 | |
| 10 | 2022 | 25 | |
| 11 | 2021 | 25 | |
| 12 | 2011 | 25 | |
| 13 | 2024 | 20 | |
| 14 | 2019 | 19 | |
| 15 | 2022 | 18 | |
| 16 | 2009 | 16 | |
| 17 | 2021 | 14 | |
| 18 | 2014 | 13 | |
| 19 | 2022 | 11 | |
| 20 | 2023 | 9 |
About Ju‐Ming Wang
Ju‐Ming Wang is a scholar working on Molecular Biology, Immunology, Oncology, Cell Biology and Cancer Research, having authored 28 papers that have together received 1.4k indexed citations. Recurring topics across this work include Biomarkers in Disease Mechanisms (7 papers), Microtubule and mitosis dynamics (3 papers), Immune cells in cancer (3 papers), Cytokine Signaling Pathways and Interactions (3 papers), Ubiquitin and proteasome pathways (2 papers), FOXO transcription factor regulation (2 papers), Cell death mechanisms and regulation (2 papers) and Cancer-related Molecular Pathways (2 papers). The work is most often cited by research in Immunology (380 citations), Oncology (460 citations), Genetics (133 citations), Cancer Research (177 citations) and Pathology and Forensic Medicine (196 citations). Ju‐Ming Wang has collaborated with scholars based in Taiwan, United States and Japan. Frequent co-authors include Hsin‐Fang Yang‐Yen, Jyh-Rong Chao, Wannhsin Chen, Min‐Liang Kuo, J. J. Yen, Richard Jove, Thomas P. Loughran, Robyn Catlett-Falcone, Marc M. Oshiro and Ravi Kothapalli. Their work appears in journals such as Clinical and Translational Medicine, Molecular and Cellular Biology, Cancer Letters, Journal of Biomedical Science and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.